迪瑞醫療(300396.SZ):取得1項醫療器械註冊變更文件、6項受理通知書
格隆匯6月8日丨迪瑞醫療(300396.SZ)公佈,公司於近日取得由國家藥品監督管理局頒發的1項《醫療器械註冊變更文件》及吉林省藥品監督管理局頒發的6項《受理通知書》,具體情況如下:
醫療器械註冊證變更事項:

上述產品的變更,豐富和延續了公司產品種類,將進一步增強公司綜合競爭力,有利於進一步提高公司的市場拓展能力,對公司未來的經營將產生積極影響。
醫療器械註冊獲得受理事項:


上述受理的產品涉及生化分析領域,目前所處的審批階段為:註冊申請受理,後續所需的審批流程為技術審評、行政審批、制證。審評在各階段所需的時間和結果均具有一定的不確定性,公司將對上述品種的後續進展情況及時履行信息披露義務。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.